Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | FABP7 | O15540 | 1/20 | 0.44 |
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | TACR2 | P21452 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29781399 | 1.00 | LMNA (0.46) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL4308357 | 0.83 | LMNA (0.47) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL30459416 | 0.83 | LMNA (0.47) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL432360 | 0.83 | LMNA (0.47) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL7105783 | 0.81 | FABP7 (0.47) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL10403921 | 0.81 | LMNA (0.46) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL1701383 | 0.79 | KDM4E (0.50) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL11216470 | 0.79 | LMNA (0.44) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL29897301 | 0.79 | KDM4E (0.50) | LMNAFABP7FABP3FABP5TSHR | |
| SCHEMBL21328032 | 0.77 | KDM4E (0.49) | LMNAFABP7FABP3FABP5TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| JP-2662311-B2 | — | — | 1997-10-08 | — | — | JP | claimed |
| EP-0553195-B1 | BIOCOMPATIBLE MICROCAPSULES | UNIV TEXAS (US) | 1997-06-11 | — | — | EP | claimed |
| EP-0437563-B1 | BIOLOGICALLY ACTIVE DRUG POLYMER DERIVATIVES | DEBIO RECH PHARMA SA (CH) | 1995-02-22 | — | — | EP | claimed |
| US-5286637-A | Biologically active drug polymer derivatives and method for preparing same | DEBIOPHARM, S.A. (CH) | 1994-02-15 | — | — | US | claimed |
| EP-0290313-B1 | PROCESS FOR OBTAINING ACTIVATED NITROSOCARBAMATES | SANOFI (FR) | 1992-03-04 | — | — | EP | claimed |
| EP-0437563-A1 | BIOLOGICALLY ACTIVE DRUG POLYMER DERIVATIVES. | DEBIOPHARM SA (CH) | 1991-07-24 | — | — | EP | claimed |
| WO-1991001758-A1 | BIOLOGICALLY ACTIVE DRUG POLYMER DERIVATIVES | DEBIOPHARM S.A. (CH) | 1991-02-21 | — | — | WO | claimed |
| US-4883903-A | FROM CHLOROETHYLAMINE, A HALOFORMATE; AND NITROSYL SULFURIC ACID | SANOFI (FR) | 1989-11-28 | — | — | US | claimed |
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | disclosed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | disclosed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | disclosed |
| US-12016904-B2 | Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-06-25 | — | — | US | disclosed |
| US-4883903-A | FROM CHLOROETHYLAMINE, A HALOFORMATE; AND NITROSYL SULFURIC ACID | SANOFI (FR) | 1989-11-28 | — | — | US | disclosed |
| US-4376731-A | 2-NITRILES THEREOF | BOEHRINGER MANNHEIM GMBH (DE) | 1983-03-15 | — | — | US | disclosed |
| US-4355172-A | Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxime derivatives | ELI LILLY AND COMPANY (US) | 1982-10-19 | — | — | US | disclosed |
| US-3991205-A | Inhibiting growth of bacteria and fungi with t-butyl 2,4,5-trichlorophenyl carbonate | STAUFFER CHEMICAL COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | LMNA 1453/4885FABP7 1564/4885FABP3 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.